此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Preserving Left Colonic Artery During Radical Resection of Rectal Cancer

2022年4月28日 更新者:Weidong Tong、Third Military Medical University

A Clinical Cohort Study on the Effect of Preserving Left Colonic Artery During Radical Resection of Rectal Cancer on Anastomotic Leakage and Oncology Efficacy

To evaluate the feasibility and clinical significance of preserving left colonic artery in rectal cancer surgery.The investigators will focus on the effect of preserving left colonic artery during radical resection of rectal cancer on anastomotic leakage and oncology efficacy.

研究概览

详细说明

The investigators performed three-dimensional (3D) reconstruction to investigate the vascular anatomy, including the inferior mesenteric artery (IMA) and left colic artery (LCA),to help make pre-operative strategies of rectal cancer surgery.The investigators will preserving the left colonic artery during rectal cancer surgery and evaluate its feasibility and clinical significance.The investigators will focus on the effect of preserving left colonic artery during radical resection of rectal cancer on anastomotic leakage and oncology efficacy.

研究类型

观察性的

注册 (实际的)

200

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Chongqing
      • Chongqing、Chongqing、中国、400000
        • zongming,Kang
      • Yuzhong、Chongqing、中国、400000
        • zongming,Kang

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 80年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

Patients who underwent laparoscopic or robotic anterior rectal resections carried out by two surgeons at Daping Hospital.

描述

Inclusion Criteria:

  1. Pathological biopsy confirmed adenocarcinoma of the rectum;
  2. Preoperative assessment of tolerance to surgery without major organ dysfunction;
  3. Patients must be able to understand and voluntarily sign written informed consent;
  4. The surgical method is laparoscopic or robotic anterior rectal cancer resection.

Exclusion Criteria:

  1. The patient cannot tolerate the operation;
  2. Refusal to sign informed consent;
  3. Patients with distant metastasis of rectal cancer;
  4. The surgical method was changed to miles or Hartman;
  5. Unable to complete the follow - up

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
Preserve the left colonic artery
Preservation of left colonic artery in rectal cancer surgery.
Preservation of left colonic artery in rectal cancer surgery.
The left colonic artery is not preserved
The left colonic artery was dissected in rectal cancer surgery
The left colonic artery was dissected in rectal cancer surgery.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
The incidence of postoperative anastomotic leakage was compared between the two groups.
大体时间:Within 30 days after surgery
The incidence of anastomotic leakage within 30 days after surgery was compared between the intervention group and the control group.
Within 30 days after surgery
The distant metastasis rates of rectal cancer between the two groups were compared.
大体时间:Two years after surgery
The incidence of distant metastasis rectal cancer within two years after surgery was compared between the intervention group and the control group.
Two years after surgery
The local recurrence rates of rectal cancer between the two groups were compared.
大体时间:Two years after surgery
The incidence of local recurrence rectal cancer within two years after surgery was compared between the intervention group and the control group.
Two years after surgery
The five-year survival rates of rectal cancer between the two groups were compared.
大体时间:Five years after surgery
The 5-year survival rates of rectal cancer in the intervention group and the control group were compared.
Five years after surgery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Wei d tong, PhD、Army Military Medical University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2018年12月1日

初级完成 (实际的)

2022年1月1日

研究完成 (实际的)

2022年1月1日

研究注册日期

首次提交

2018年12月9日

首先提交符合 QC 标准的

2018年12月11日

首次发布 (实际的)

2018年12月14日

研究记录更新

最后更新发布 (实际的)

2022年5月4日

上次提交的符合 QC 标准的更新

2022年4月28日

最后验证

2022年4月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅